$347 — Premium Tier

Biocompatibility & TRA Toolkit: ISO 10993 Biological Evaluation Templates

Biocompatibility and TRA Toolkit — biological evaluation plan, toxicological risk assessment, chemical characterization report, test selection justification, BER summary, and FDA submission checklist.

Get the Toolkit — $347

7-day money-back guarantee • One-time purchase • Instant download

What's Included

Biological Evaluation Plan Template (ISO 10993-1:2018)
Toxicological Risk Assessment (TRA) Report Template
Chemical Characterization Report Structure Template (ISO 10993-18)
Biocompatibility Test Selection Justification Template
Biological Evaluation Report (BER) Summary Template
FDA Biocompatibility Submission Checklist (510k and PMA)

Benefits

BEP template aligned with FDA 2023 Use of ISO 10993-1 guidance
TRA template integrates chemical characterization data for testing alternative pathway
Test selection justification documents each ISO 10993-1 Table A.1 endpoint decision
BER summary integrates all evaluation components in FDA submission format

Is This For You?

This toolkit is designed for teams facing these challenges:

FDA AI request citing biocompatibility documentation gaps in 510k submission
Chemical characterization data exists but TRA not documented to support testing alternative
Test selection rationale missing for exempted endpoints
BER summary not structured for FDA reviewer expectations

Who This Is For

Biocompatibility scientists preparing ISO 10993 evaluation packagesRA leads compiling biocompatibility documentation for 510k or PMA submissionsMaterials engineers conducting device material characterizationRegulatory consultants supporting biocompatibility strategy for novel materials

Frequently Asked Questions

When can chemical characterization replace biocompatibility testing?

When chemical characterization demonstrates extractables below the analytical threshold or TRA confirms they are below tolerable intake. FDA 2023 guidance provides the framework for this determination.

Which ISO 10993 edition does FDA currently accept?

FDA aligns with ISO 10993-1:2018 per its 2023 guidance. Both the testing approach and chemical characterization plus TRA approach are accepted.

Related Toolkits

Biocompatibility Strategy

$297

Design Controls

$247

ISO 14971 Risk Management

$247

Ready to Get Started?

Download immediately after purchase. All templates are editable Word and Excel files.

Get the Toolkit — $347

7-day money-back guarantee